SOD1 and amyotrophic lateral sclerosis: Improvement of the NAD+ recovery pathway reverses the toxicity of primary astrocytes expressing the SOD1 mutation related to ALS, decreasing the mitochondrial production of ROS and reversing the neurotoxic effects (Harlan et al., 2016).